| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $17.47 ▼ -0.69% | Yesterday | $17.64 ▲ +0.29% | Tomorrow's Amylyx Pharmaceuticals Inc. Common Stock (AMLX) setup is anchored to $17.59 and targets $17.47 (-0.69%). The near-term read is downside; watch $18.12 / $17.06 because daily realized volatility is about 3.57%. |
Tomorrow's Amylyx Pharmaceuticals Inc. Common Stock (AMLX) setup is anchored to $17.59 and targets $17.47 (-0.69%). The near-term read is downside; watch $18.12 / $17.06 because daily realized volatility is about 3.57%. | ||||
| Week | $17.21 ▼ -2.16% | Last Week | $17.75 ▲ +0.91% | The 7-day Amylyx Pharmaceuticals Inc. Common Stock model moves from $17.75 to $17.21 (-2.16%). It gives downside momentum context for this stock, so breaks around $18.12 / $17.06 matter more than a single tick. |
The 7-day Amylyx Pharmaceuticals Inc. Common Stock model moves from $17.75 to $17.21 (-2.16%). It gives downside momentum context for this stock, so breaks around $18.12 / $17.06 matter more than a single tick. | ||||
| Month | $16.78 ▼ -4.59% | Last Month | $17.93 ▲ +1.93% | The 1-month Amylyx Pharmaceuticals Inc. Common Stock target is $16.78 (-4.59%), compared with the live reference near $17.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Amylyx Pharmaceuticals Inc. Common Stock target is $16.78 (-4.59%), compared with the live reference near $17.59. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $16.14 ▼ -8.24% | Last Year | $18.20 ▲ +3.46% | The 1-year Amylyx Pharmaceuticals Inc. Common Stock scenario points to $16.14 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Amylyx Pharmaceuticals Inc. Common Stock scenario points to $16.14 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $14.63 ▼ -16.80% | 5 Years Ago | $18.83 ▲ +7.06% | The 5-year Amylyx Pharmaceuticals Inc. Common Stock view is $14.63 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Amylyx Pharmaceuticals Inc. Common Stock view is $14.63 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $17.59 | Mid |
| Daily Change | +0.11% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $17.59 | Daily Change | +0.11% |
| Market Cap | $1.94B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.